Odyssey Therapeutics News

Latest Odyssey Therapeutics Stock News & ODTX Headlines

Odyssey Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

11 days ago | globenewswire.com

Odyssey Therapeutics Highlights OD-001 Phase IIa UC Data, Sets 2027 Trial Readouts

21 days ago | marketbeat.com

Odyssey Therapeutics, Inc. (ODTX) Discusses Additional Phase IIa Data for OD-001 in Ulcerative Colitis from UEG Week Presentation Transcript

25 days ago | seekingalpha.com

Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026

a month ago | globenewswire.com

Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026

a month ago | globenewswire.com

Odyssey Therapeutics, Inc. (NASDAQ:ODTX) Stock Has Consensus Target Price of $35.75 According to Brokerages

a month ago | defenseworld.net

Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum

2 months ago | globenewswire.com

Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

3 months ago | globenewswire.com

Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

5 months ago | globenewswire.com

Healthcare IPOs Raise $4.7 Billion As Odyssey, Mobia Debuts Slip

6 months ago | gurufocus.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

ODTX

Odyssey Therapeutics

$ 19.14

-4.78%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated a day ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Odyssey Therapeutics News

Latest Odyssey Therapeutics Stock News & ODTX Headlines

Download App

People Also Watch

Explore our Tools